From: Impact of delays in radiotherapy of head and neck cancer on outcome
Characteristics | No. (%) |
---|---|
Gender | |
Female | 35 (13.2%) |
Male | 227 (86.8%) |
Age (years)a) | 60.6 ± 9.9 (38.9–89.3) |
Tumor locationb) | |
Oral cavity | 15 (5.5%) |
Oropharynx | 133 (48.7%) |
Hypopharynx | 53 (19.4%) |
Larynx | 72 (26.4%) |
Tumor stageb) | |
Stage I | 12 (4.4%) |
Stage II | 50 (18.3%) |
Stage III | 48 (17.6%) |
Stage IV | 163 (59.7%) |
Treatmentb) | |
Radiotherapy | 157 (57.5%) |
Concurrent chemoradiotherapy | 116 (42.5%) |
RT duration (days)a) | 50.2 ± 6.7 (35–80) |
Time to treatment interventiona) | 35.6 ± 14.9 (7–90) |